Zhu Y, Zerdes I, Matikas A, Cruz IR, et al. The role of serum thymidine kinase 1 activity in neoadjuvant-treated HER2-positive breast cancer: biomarker analysis from the Swedish phase II randomized PREDIX HER2 trial. Breast Cancer Res Treat 2024 Jan 4. doi: 10.1007/s10549-023-07200.
PMID: 38175448